Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Aug 23, 2011


CTGT this week launched a number of new tests for autosomal recessive osteogenesis imperfect. CTGT now offers both DNA sequencing and deletion/ duplication tests on its HDT Array for the following OI types and genes:

  • Osteogenesis imperfecta, type IIB and VII/CRTAP Osteogenesis imperfecta, type VI/FKBP10
  • Osteogenesis imperfecta, type VIII/LEPRE1
  • Osteogenesis imperfecta, type IX/PPIB
  • Osteogenesis imperfecta, type X/SERPINH1 Osteogenesis imperfecta, type XI/SP7
  • Osteogenesis imperfecta, type XII/SERPINF1

CTGT's custom designed High-Density Targeted Array is manufactured by Agilent Technologies on its G3 SurePrint comparative genomic hybridization platform.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.